- call +1-201-465-4211
- email sales@mrinsights.biz
Head and neck cancer begins in squamous cells that line the mucosal surfaces of the head and neck such as, inside the mouth, the nose, and the throat. The head and neck cancers include specific areas of the body such as oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and salivary glands. Alcohol and tobacco are the two most common risk factors for head and neck cancers. Other risk factors for head and neck cancers include consumption of preserved or salted foods, occupational exposure to wood dust, Epstein-Barr virus infection, and poor oral hygiene.
Scope of the Report:
This report studies the Head and Neck Cancer Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Head and Neck Cancer Diagnostics market by product type and applications/end industries.
The market for head and neck cancer diagnostics is expected to increase year on year with an increasing incidence of the disease. Though this form of cancer is not prevalent in all its forms in the US, it has increased presence and incidence in countries of Asia, Africa and to some extent Europe, making its screening and early detection of high importance to affect proper treatment and care. Proper detection at an early stage can lead to proper treatment and long healthier life. Rise in the aging population that increased the prevalence of chronic diseases, especially head and neck related cancers, increasing awareness towards cancer, and rise in the healthcare expenditure of people and government. However, Low Adoption Rate of Digital Technology Based Systems, Conventional CT and MRI Scanners, Excise Duty Imposed on Sale of Medical Devices in Mature Markets
Africa and Asia-Pacific, along with parts of Europe, and certain regions in South America, have the highest incidence of head and neck cancer cases, as these regions are prone to higher intake of alcohol and tobacco products. In Asia-Pacific and Africa, India, China, and South Africa are the biggest markets for the overall head and neck cancer diagnostics market.
The global Head and Neck Cancer Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Head and Neck Cancer Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
GE Healthcare
Philips Healthcare
Siemens Healthcare
Varian Medical Systems
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Diagnostic Imaging
Endoscopy Screening
Bioscopy Screening
Blood Tests
Dental Diagnostic
Others
Market Segment by Applications, can be divided into
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Head and Neck Cancer Diagnostics Market Overview
1.1 Product Overview and Scope of Head and Neck Cancer Diagnostics
1.2 Classification of Head and Neck Cancer Diagnostics by Types
1.2.1 Global Head and Neck Cancer Diagnostics Revenue Comparison by Types (2017-2023)
1.2.2 Global Head and Neck Cancer Diagnostics Revenue Market Share by Types in 2017
1.2.3 Diagnostic Imaging
1.2.4 Endoscopy Screening
1.2.5 Bioscopy Screening
1.2.6 Blood Tests
1.2.7 Dental Diagnostic
1.2.8 Others
1.3 Global Head and Neck Cancer Diagnostics Market by Application
1.3.1 Global Head and Neck Cancer Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Head and Neck Cancer Diagnostics Market by Regions
1.4.1 Global Head and Neck Cancer Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Head and Neck Cancer Diagnostics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Head and Neck Cancer Diagnostics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Head and Neck Cancer Diagnostics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Head and Neck Cancer Diagnostics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Head and Neck Cancer Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of Head and Neck Cancer Diagnostics (2013-2023)
2 Manufacturers Profiles
2.1 GE Healthcare
2.1.1 Business Overview
2.1.2 Head and Neck Cancer Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GE Healthcare Head and Neck Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Philips Healthcare
2.2.1 Business Overview
2.2.2 Head and Neck Cancer Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Philips Healthcare Head and Neck Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Siemens Healthcare
2.3.1 Business Overview
2.3.2 Head and Neck Cancer Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Siemens Healthcare Head and Neck Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Varian Medical Systems
2.4.1 Business Overview
2.4.2 Head and Neck Cancer Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Varian Medical Systems Head and Neck Cancer Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Head and Neck Cancer Diagnostics Market Competition, by Players
3.1 Global Head and Neck Cancer Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Head and Neck Cancer Diagnostics Players Market Share
3.2.2 Top 10 Head and Neck Cancer Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Head and Neck Cancer Diagnostics Market Size by Regions
4.1 Global Head and Neck Cancer Diagnostics Revenue and Market Share by Regions
4.2 North America Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
5 North America Head and Neck Cancer Diagnostics Revenue by Countries
5.1 North America Head and Neck Cancer Diagnostics Revenue by Countries (2013-2018)
5.2 USA Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
6 Europe Head and Neck Cancer Diagnostics Revenue by Countries
6.1 Europe Head and Neck Cancer Diagnostics Revenue by Countries (2013-2018)
6.2 Germany Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Head and Neck Cancer Diagnostics Revenue by Countries
7.1 Asia-Pacific Head and Neck Cancer Diagnostics Revenue by Countries (2013-2018)
7.2 China Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
8 South America Head and Neck Cancer Diagnostics Revenue by Countries
8.1 South America Head and Neck Cancer Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Head and Neck Cancer Diagnostics by Countries
9.1 Middle East and Africa Head and Neck Cancer Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa Head and Neck Cancer Diagnostics Revenue and Growth Rate (2013-2018)
10 Global Head and Neck Cancer Diagnostics Market Segment by Type
10.1 Global Head and Neck Cancer Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global Head and Neck Cancer Diagnostics Market Forecast by Type (2018-2023)
10.3 Diagnostic Imaging Revenue Growth Rate (2013-2023)
10.4 Endoscopy Screening Revenue Growth Rate (2013-2023)
10.5 Bioscopy Screening Revenue Growth Rate (2013-2023)
10.6 Blood Tests Revenue Growth Rate (2013-2023)
10.7 Dental Diagnostic Revenue Growth Rate (2013-2023)
10.8 Others Revenue Growth Rate (2013-2023)
11 Global Head and Neck Cancer Diagnostics Market Segment by Application
11.1 Global Head and Neck Cancer Diagnostics Revenue Market Share by Application (2013-2018)
11.2 Head and Neck Cancer Diagnostics Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Specialty Clinics Revenue Growth (2013-2018)
11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018)
12 Global Head and Neck Cancer Diagnostics Market Size Forecast (2018-2023)
12.1 Global Head and Neck Cancer Diagnostics Market Size Forecast (2018-2023)
12.2 Global Head and Neck Cancer Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America Head and Neck Cancer Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe Head and Neck Cancer Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Head and Neck Cancer Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America Head and Neck Cancer Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Head and Neck Cancer Diagnostics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Head and Neck Cancer Diagnostics Picture
Table Product Specifications of Head and Neck Cancer Diagnostics
Table Global Head and Neck Cancer Diagnostics and Revenue (
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
